The heterogeneity of tumour immune microenvironment revealing the CRABP2/CD69 signature discriminates distinct clinical outcomes in breast cancer. - Mei, Jie; Cai, Yun; Chen, Lingyan; Wu, Youqing; Liu, Jiayu; Qian, Zhiwen; Jiang, Ying; Zhang, Ping; Xia, Tiansong; Pan, Xiang; Zhang, Yan (British Journal of Cancer, 2023)